About
Technology
Issues
FAQ
Search
Profile
Schools
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Scientometrics
Avg. Impact Factor
Discipline Ranks
h
-index
g
-index
★★
Articles
★★★
Articles
Article Citations
Citation Distribution
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Institutions
›
North Central Cancer Treatment Group
›
top-articles
North Central Cancer Treatment Group
5
(top 1%)
papers
177
(top 1%)
citations
3
(top 1%)
h
-index
5
(top 1%)
g
-index
5
all documents
184
doc citations
106
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: Data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803
European Journal of Cancer
2011
101
2
Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)
Breast Cancer Research and Treatment
2011
59
3
D7-07: A phase II NCCTG “Window of Opportunity Front-line” study of the mTOR Inhibitor, CCI-779 (Temsirolimus) given as a single agent in patients with advanced NSCLC
Journal of Thoracic Oncology
2007
20
4
Systematic education and utilization of volunteer patient advocates for cancer clinical trial information dissemination at NCCTG community sites
Journal of Clinical Oncology
2004
3
5
Systematic education and utilization of volunteer patient advocates for cancer clinical trial information dissemination at NCCTG community sites
Journal of Clinical Oncology
2004
1
site/software ©
exaly
; All materials licenced under
CC by-SA
.